Health Condition 1: D509- Iron deficiency anemia, unspecified
Conditions
Interventions
Intervention1: Ferrum Phos 6X: single blind cross over clinical trial,we are giving Ferrum phos 6X to one group (Group-A) and another group will be given placebo (sugar of milk) for 9 months (Group-B)
Sponsors
Dr Indrajeet P Shah
Adven Biotech Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age group 10â??19 years. 2.adolescent school girls suffering from mild to moderate Anaemia with Haemoglobin ranging between 7-12 g/dL 3.Subjects diagnosed on the basis of clinical presentation, laboratory investigation like Hb gm % & peripheral smear. 4.Patients from all communities, female sex, different socio-economic status is included.
Exclusion criteria
Exclusion criteria: 1.Anaemia with established and advanced pathological changes i.e. Leukaemia, Multiple myeloma, sickle cell Anaemia, Thalassemia. 2.Patients requiring hospitalization due to surgical intervention or due to other diseases with anaemia. 3.Underlying chronic illness like immunocompromised, Pulmonary Tuberculosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effect of Ferrum Phos 6X on hemoglobin level in cases of Iron Deficiency Anaemia.Timepoint: investigation will be done at 0 day and at every 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To improve the quality of lifeTimepoint: sf-12 questionnaire will be done at 0 day and at every 3 months | — |
Countries
India
Contacts
Public ContactDr Indrajeet P Shah
Dr D. Y. Patil Vidyapeeth, Pune
Outcome results
None listed